Acadian Asset Management
WVE icon

Acadian Asset Management’s Wave Life Sciences WVE Stock Holding History

Acadian Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74K Buy
12,806
+3,051
+31% +$20.2K ﹤0.01% 1810
2026
Q1 		$70K Buy
9,755
+3,932
+68% +$51.2K ﹤0.01% 1813
2025
Q4 		$98K Buy
+5,823
New +$59.2K ﹤0.01% 1676
2024
Q4 		– Sell
-3,500
Closed -$28K – 2220
2024
Q3 		$28K Buy
+3,500
New +$20.9K ﹤0.01% 1930

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Acadian Asset Management's WVE Position: Q2 2026 in Review

Acadian Asset Management increased its Wave Life Sciences (WVE) stake by 31% in Q2 2026, buying an estimated $20.2K and bringing the position to 12,806 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Acadian Asset Management first reported a position in WVE in Q3 2024 and has held it in 4 quarters since. The position peaked at $98K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Acadian Asset Management held 12,806 shares of Wave Life Sciences worth $74K as of Q2 2026.
  • Acadian Asset Management bought 3,051 Wave Life Sciences shares in Q2 2026, an estimated $20.2K.
  • Wave Life Sciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1810 holding.
  • Acadian Asset Management first reported a position in Wave Life Sciences in Q3 2024 and has held it in 4 quarters since.
  • Acadian Asset Management's Wave Life Sciences position peaked at $98K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.